BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jesse Hinton, Richard Callan, Charlie Bodine, Wayne Glasgow, Steve Brower, Shi-Wen Jiang, Jinping Li. Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomasExpert Review of Molecular Diagnostics 2013; 13(5): 431 doi: 10.1586/erm.13.38
2
Guoxiang Xie, Lingeng Lu, Yunping Qiu, Quanxing Ni, Wei Zhang, Yu-Tang Gao, Harvey A. Risch, Herbert Yu, Wei Jia. Plasma Metabolite Biomarkers for the Detection of Pancreatic CancerJournal of Proteome Research 2015; 14(2): 1195 doi: 10.1021/pr501135f
3
Gang Zhou, David Chiu, Dajiang Qin, Lizhi Niu, Jinlei Cai, Lihua He, Wenhao Huang, Kecheng Xu. The Efficacy Evaluation of Cryosurgery in Pancreatic Cancer Patients with the Expression of CD44v6, Integrin-β1, CA199, and CEAMolecular Biotechnology 2012; 52(1): 59 doi: 10.1007/s12033-011-9474-7
4
Xueyan Li, Xiaozhong Guo, Hongyu Li, Hao Lin, Yingwei Sun. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancerTumor Biology 2014; 35(6): 5281 doi: 10.1007/s13277-014-1687-5
5
Zhe Huang, Fang Liu. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysisTumor Biology 2014; 35(8): 7459 doi: 10.1007/s13277-014-1995-9
6
Ji-Cong Gui, Wei-Li Yan, Xing-Dang Liu. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysisClinical and Experimental Medicine 2014; 14(2): 225 doi: 10.1007/s10238-013-0234-9
7
Y.-F. Chen, J.-Y. Wang, C.-H. Wu, F.-M. Chen, T.-L. Cheng, S.-R. Lin. Detection of circulating cancer cells with K-ras oncogene using membrane arrayCancer Letters 2005; 229(1): 115 doi: 10.1016/j.canlet.2004.12.026
8
Sukhwinder Kaur, Michael J Baine, Maneesh Jain, Aaron R Sasson, Surinder K Batra. Early diagnosis of pancreatic cancer: challenges and new developmentsBiomarkers in Medicine 2012; 6(5): 597 doi: 10.2217/bmm.12.69
9
Subhankar Chakraborty, Michael J. Baine, Aaron R. Sasson, Surinder K. Batra. Current status of molecular markers for early detection of sporadic pancreatic cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011; 1815(1): 44 doi: 10.1016/j.bbcan.2010.09.002
10
S. Bünger, T. Laubert, U. J. Roblick, J. K. Habermann. Serum biomarkers for improved diagnostic of pancreatic cancer: a current overviewJournal of Cancer Research and Clinical Oncology 2011; 137(3): 375 doi: 10.1007/s00432-010-0965-x
11
Marcus Bahra, Florian Lordick, Manfred P. Lutz, Matthias Glanemann, Peter Neuhaus. Viszeralmedizin2015; : 557 doi: 10.1007/978-3-642-14301-4_38
12
H. Oettle, A. Goerke, A. Kaiser, V. Budach, P. Vogel. Therapiekonzepte Onkologie2007; : 713 doi: 10.1007/978-3-540-28978-4_34
13
Ian D Norton. Pancreatic cancer: Tissue is the issueJournal of Gastroenterology and Hepatology 2008; 23(4): 507 doi: 10.1111/j.1440-1746.2008.05399.x
14
Si-Biao Su, Shan-Yu Qin, Wen Chen, Wei Luo, Hai-Xing Jiang. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitisWorld Journal of Gastroenterology 2015; 21(14): 4323-4333 doi: 10.3748/wjg.v21.i14.4323
15
Bo Deng, Qun-You Tan, Xiao-Qing Fan, Yao-Guang Jiang, Yun-Ping Zhao, Jing-Hai Zhou, Yong-Gang Liang, Ru-Wen Wang. Clinical Value of Assaying Tumor Supplied Group of Factor/Tumor Specific Growth Factor in Patients With Solitary Pulmonary NoduleClinical Lung Cancer 2011; 12(3): 192 doi: 10.1016/j.cllc.2011.03.017
16
Shuichi MITSUNAGA, Motohiro KOJIMA, Masafumi IKEDA, Atsushi OCHIAI. Serum microRNAs as tumor markers for diagnosis of pancreatic cancerSuizo 2017; 32(1): 56 doi: 10.2958/suizo.32.56
17
Pengjiao Zeng, Hui Li, Yulong Chen, Haitao Pei, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part AProgress in Molecular Biology and Translational Science 2019; 162: 253 doi: 10.1016/bs.pmbts.2018.12.010
18
Vitor Faca, Samir Hanash. In-depth quantitative proteomics for pancreatic cancer biomarker discoveryExpert Opinion on Medical Diagnostics 2007; 1(1): 81 doi: 10.1517/17530059.1.1.81
19
Piotr Hogendorf, Adam Durczyński, Aleksander Skulimowski, Anna Kumor, Grażyna Poznańska, Janusz Strzelczyk. Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary reportCancer Biomarkers 2016; 16(4): 537 doi: 10.3233/CBM-160595
20
Jennifer M. Curry, Kyle J. Thompson, Shanti G. Rao, Dahlia M. Besmer, Andrea M. Murphy, Valery Z. Grdzelishvili, William A. Ahrens, Iain H. McKillop, David Sindram, David A. Iannitti, John B. Martinie, Pinku Mukherjee. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancerJournal of Surgical Oncology 2013; 107(7): 713 doi: 10.1002/jso.23316
21
B Yu, PZ Xu, QW Wang, H Zhou, HX Zhou. Clinical Value of Tumour Specific Growth Factor (TSGF) and Carbohydrate Antigen-125 (CA-125) in Carcinoma of the EndometriumJournal of International Medical Research 2009; 37(3): 878 doi: 10.1177/147323000903700333
22
Anna S. Gerdtsson, Núria Malats, Anna Säll, Francisco X. Real, Miquel Porta, Petter Skoog, Helena Persson, Christer Wingren, Carl A. K. Borrebaeck. A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal AdenocarcinomaInternational Journal of Proteomics 2015; 2015: 1 doi: 10.1155/2015/587250
23
K.S. Goonetilleke, A.K. Siriwardena. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancerEuropean Journal of Surgical Oncology (EJSO) 2007; 33(3): 266 doi: 10.1016/j.ejso.2006.10.004
24
Gunnar Folprecht, Michael Geißler, Diana Lüftner, Helmut Öttle, Kurt Possinger, Anne C. Regierer. Facharzt Hämatologie Onkologie2007; : 573 doi: 10.1016/B978-343723770-6.50021-1
25
Siqi Yu, Guizheng Zou, Qin Wei. Ultrasensitive electrochemical immunosensor for quantitative detection of tumor specific growth factor by using Ag@CeO2 nanocomposite as labelsTalanta 2016; : 11 doi: 10.1016/j.talanta.2016.04.050
26
Julia Mayerle, Holger Kalthoff, Regina Reszka, Beate Kamlage, Erik Peter, Bodo Schniewind, Sandra González Maldonado, Christian Pilarsky, Claus-Dieter Heidecke, Philipp Schatz, Marius Distler, Jonas A Scheiber, Ujjwal M Mahajan, F Ulrich Weiss, Robert Grützmann, Markus M Lerch. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitisGut 2018; 67(1): 128 doi: 10.1136/gutjnl-2016-312432
27
Pengjun Zhang, Meng Zou, Xinyu Wen, Feng Gu, Juan Li, Gaixia Liu, Jingxiao Dong, Xinxin Deng, Jing Gao, Xiaolong Li, Xingwang Jia, Zhennan Dong, Luonan Chen, Yong Wang, Yaping Tian. Development of serum parameters panels for the early detection of pancreatic cancerInternational Journal of Cancer 2014; 134(11): 2646 doi: 10.1002/ijc.28584
28
Eseosaserea Igbinigie, Fengbiao Guo, Shi-Wen Jiang, Cullen Kelley, Jinping Li. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinomaClinica Chimica Acta 2019; 488: 226 doi: 10.1016/j.cca.2018.11.023
29
Yoshihito Ide, Eiji Miyoshi, Tsutomu Nakagawa, Jianguo Gu, Masahiro Tanemura, Toshiro Nishida, Toshinori Ito, Harumi Yamamoto, Yasunori Kozutsumi, Naoyuki Taniguchi. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancerBiochemical and Biophysical Research Communications 2006; 341(2): 478 doi: 10.1016/j.bbrc.2005.12.208
30
Facharzt Hämatologie Onkologie2012; : e1 doi: 10.1016/B978-3-437-21212-3.10048-7
31
Mark Bloomston, Tanios S. Bekaii-Saab, Kavitha Kosuri, Sarah M. Cowgill, W. Scott Melvin, E. Christopher Ellison, Peter Muscarella. Preoperative Carbohydrate Antigen 19-9 is Most Predictive of Malignancy in Older Jaundiced Patients Undergoing Pancreatic ResectionPancreas 2006; 33(3): 246 doi: 10.1097/01.mpa.0000236726.34296.df
32
Gang Zhou, Lizhi Niu, David Chiu, Lihua He, Kecheng Xu. Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patientsBiotechnology Letters 2012; 34(7): 1235 doi: 10.1007/s10529-012-0908-5